A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age45-55
SponsorChina Academy of Chinese Medical Sciences

About this trial

To evaluate the clinical efficacy of the real-world Liuwei Dihuang pills for the treatment of female menopausal syndromes, and to provide a basis for effective, safe and rational clinical use of the drug.

Eligibility criteria

Qualifiers

Age: 45-55 years old

Patients with menopausal syndrome using Liuwei Dihuang Pills

Kidney Yin Deficiency Syndrome

Disqualifiers

Individuals allergic to any components of the drug or excipients;

Individuals with other endocrine diseases;

Individuals with organic lesions of the reproductive system;

Individuals who have undergone bilateral oophorectomy, hysterectomy, or have ovarian dysfunction;

Trial design

Treatments tested in this trial

  • Liuwei Dihuang pills

Treatment groups

1,000 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

China Academy of Chinese Medical Sciences

Lead sponsor

Lanxi Hospital of Traditional Chinese Medicine

Collaborator

First Affiliated Hospital of Harbin Medical University

Collaborator